Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shruti, Raghunathan"'
Autor:
Aditya Girish, Ketan Jolly, Nijmeh Alsaadi, Maria de la Fuente, Arielle Recchione, Ran An, Dante Disharoon, Zachary Secunda, Shruti Raghunathan, Norman F Luc, Cian Desai, Elizabeth Knauss, Xu Han, Keren Hu, Hanyang Wang, Ujjal Didar Singh Sekhon, Nathan Rohner, Umut A Gurkan, Marvin Nieman, Matthew D. Neal, Anirban Sen Gupta
Publikováno v:
ACS Nano
Severe hemorrhage associated with trauma, surgery, and congenital or drug-induced coagulopathies can be life-threatening and requires rapid hemostatic management via topical, intracavitary, or intravenous routes. For injuries that are not easily acce
Autor:
Michelle A. Cruz, Dillon Bohinc, Elizabeth A. Andraska, Jurgis Alvikas, Shruti Raghunathan, Nicole A. Masters, Nadine D. van Kleef, Kara L. Bane, Kathryn Hart, Kathryn Medrow, Michael Sun, Haitao Liu, Shannon Haldeman, Ankush Banerjee, Emma M. Lessieur, Kara Hageman, Agharnan Gandhi, Maria de la Fuente, Marvin T. Nieman, Timothy S. Kern, Coen Maas, Steven de Maat, Keith B. Neeves, Matthew D. Neal, Anirban Sen Gupta, Evi X. Stavrou
Publikováno v:
Nature nanotechnology, vol 17, iss 9
Nat Nanotechnol
Nat Nanotechnol
Targeted drug delivery to disease-associated activated neutrophils can provide novel therapeutic opportunities while avoiding systemic effects on immune functions. We created a nanomedicine platform that uniquely utilizes an α(1)-antitrypsin-derived
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:1535-1549
Platelets are anucleate cell-fragments derived predominantly from megakaryocytes in the bone marrow and released in the blood circulation, with a normal count of 150 000-40 000 per μl and a lifespan of approximately 10 days in humans. A primary role
Autor:
Gil Covarrubias, Felicia He, Shruti Raghunathan, Oguz Turan, Pubudu M Peiris, William P Schiemann, Efstathios Karathanasis
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0220474 (2019)
Metastasis is responsible for the majority of deaths of breast cancer patients. While cytotoxic drugs are available with high potency to kill breast cancer cells, they are not designed to specifically seek and navigate in the dynamic and continuously
Externí odkaz:
https://doaj.org/article/5c44b289733f48338eee9ec13bb83074
Autor:
Michelle A, Cruz, Dillon, Bohinc, Elizabeth A, Andraska, Jurgis, Alvikas, Shruti, Raghunathan, Nicole A, Masters, Nadine D, van Kleef, Kara L, Bane, Kathryn, Hart, Kathryn, Medrow, Michael, Sun, Haitao, Liu, Shannon, Haldeman, Ankush, Banerjee, Emma M, Lessieur, Kara, Hageman, Agharnan, Gandhi, Maria, de la Fuente, Marvin T, Nieman, Timothy S, Kern, Coen, Maas, Steven, de Maat, Keith B, Neeves, Matthew D, Neal, Anirban, Sen Gupta, Evi X, Stavrou
Publikováno v:
Nature nanotechnology. 17(9)
Targeted drug delivery to disease-associated activated neutrophils can provide novel therapeutic opportunities while avoiding systemic effects on immune functions. We created a nanomedicine platform that uniquely utilizes an α